16 /100
LOW RISK
Score updated May 29, 2026

DSGN — Design Therapeutics, Inc. Dilution Risk Tracker

Track DSGN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track DSGN — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
40
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for DSGN.
🔔 Track DSGN — Get forecast alerts →

💹 Market Data

Market Cap$670.79M
Shares Outstanding62.46M
Float35.36M
Cash$222.82M
Debt$2.73M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 6.4% shares (2025Q4 vs prior)
119 institutional holders · 38.76M shares
#1 SR One Capital Management, LP 6.53M shares
#2 Point72 Asset Management, L.P. 5.37M shares
#3 Logos Global Management LP 2.50M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest2.32M
Days to Cover3.6
% of Float6.6%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2021
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track DSGN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking DSGN — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for DSGN
📊 DSGN FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 DSGN Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.